English

ImmunoBiotics, Inc.

EDGAR

Quarterly report (10-Q) · filed 2010-11-22

12 filing records in this dataset, filed from 2008-04-10 to 2010-11-22. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.5 thousand USD

2010-03-31 · USD

Exact inputs and evidence

Revenue: 2500 USD Source

Net margin

-5,011%

2010-03-31 · %

Exact inputs and evidence

Net Income: -125275 USD Source
Revenue: 2500 USD Source

Operating cash flow

-27.6 thousand USD

2010-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -27634 USD Source

Cash and cash equivalents: 8.26 thousand USD 2010-03-31 Source
Exact value

8255 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-851 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Net income: -295335 USD · 2009-01-01 – 2009-06-30 Source
Net income: -36520 USD · 2009-01-01 – 2009-03-31 Source
Net income: -566483 USD · 2009-01-01 – 2009-09-30 Source
Net income: -295335 USD · 2009-01-01 – 2009-06-30 Source
Net income: -762541 USD · 2009-01-01 – 2009-12-31 Source
Net income: -566483 USD · 2009-01-01 – 2009-09-30 Source
Net income: -125275 USD · 2010-01-01 – 2010-03-31 Source

Operating cash flow

-233 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Operating cash flow: -69239 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -4242 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -103575 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -69239 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -209314 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: -103575 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -27634 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-11-22.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2007-12-31
operating income: No compatible figures in this window
Net income: 4 of 11 periods available· newest 2009-12-31
Operating cash flow: 4 of 11 periods available· newest 2009-12-31
capital expenditure: No compatible figures in this window
Total assets: 4 of 11 periods available· newest 2009-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2009-12-31
Current liabilities: 4 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 332,796

Prior period

−USD 429,745

2008-01-01 – 2008-12-31
Current period

−USD 762,541

2009-01-01 – 2009-12-31

Exact inputs and evidence

-762541 − -429745 = -332796 USD

-429745 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-762541 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ImmunoBiotics, Inc. · 2009-12-31 ImmunoBiotics, Inc. (edgar:1413579) Year-over-year change in Net income: -332796 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -762541 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4328 Input fundies:NetIncome: -429745 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4328
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 216,816

Prior period

−USD 426,130

2008-01-01 – 2008-12-31
Current period

−USD 209,314

2009-01-01 – 2009-12-31

Exact inputs and evidence

-209314 − -426130 = 216816 USD

-426130 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-209314 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ImmunoBiotics, Inc. · 2009-12-31 ImmunoBiotics, Inc. (edgar:1413579) Year-over-year change in Operating cash flow: 216816 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -209314 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4533 Input fundies:OperatingCashFlow: -426130 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4533
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 2,500 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 230,123 −9,205% of revenue

Cash

Operating cash flow −USD 75,357 −3,014% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	0	Unavailable	Unavailable	Unavailable	-3950	Unavailable	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -3950 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -50 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	2500	Unavailable	Unavailable	Unavailable	-230123	Unavailable	Source 2007-01-01 – 2007-12-31: 2500 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -230123 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -75357 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.5K 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	2500	Revenue: 2500 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 2500 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -9,204.9% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
2007-12-31	Operating margin	Not reported	Revenue: 2500 Open source
20062006-12-31	Net margin	Not reported	Net Income: -3950 Open source Revenue: 0 Open source
20072007-12-31	Net margin	-9,204.9%	Net Income: -230123 Open source Revenue: 2500 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -50 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 2500 Open source Operating Cash Flow: -75357 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -75.4K 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	-50	Operating Cash Flow: -50 Open source
20072007-12-31	Operating cash flow	-75357	Operating Cash Flow: -75357 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -50 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -75357 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 4303 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 7800 Open source
20072007-12-31	Current assets / current liabilities	0.02×	Current Assets: 2500 Open source Current Liabilities: 105066 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 3,950 Exact value Exact value: -3950 USD 2006-01-01 – 2006-12-31: -3950 USD Inspect Net Income Open source Share or cite Citation for Net Income · ImmunoBiotics, Inc. · 2006-12-31 ImmunoBiotics, Inc. (edgar:1413579) Net Income: -3950 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3950 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-08-000657.txt#5113 The citation records this snapshot. The page link may show a newer release later.	−USD 50 Exact value Exact value: -50 USD 2006-01-01 – 2006-12-31: -50 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ImmunoBiotics, Inc. · 2006-12-31 ImmunoBiotics, Inc. (edgar:1413579) Operating Cash Flow: -50 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-08-000657.txt#5222 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 230,123 Exact value Exact value: -230123 USD 2007-01-01 – 2007-12-31: -230123 USD Inspect Net Income Open source Share or cite Citation for Net Income · ImmunoBiotics, Inc. · 2007-12-31 ImmunoBiotics, Inc. (edgar:1413579) Net Income: -230123 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -230123 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-09-000836.txt#5606 The citation records this snapshot. The page link may show a newer release later.	−USD 75,357 Exact value Exact value: -75357 USD 2007-01-01 – 2007-12-31: -75357 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ImmunoBiotics, Inc. · 2007-12-31 ImmunoBiotics, Inc. (edgar:1413579) Operating Cash Flow: -75357 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -75357 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-09-000836.txt#5768 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 429,745 Exact value Exact value: -429745 USD 2008-01-01 – 2008-12-31: -429745 USD Inspect Net Income Open source Share or cite Citation for Net Income · ImmunoBiotics, Inc. · 2008-12-31 ImmunoBiotics, Inc. (edgar:1413579) Net Income: -429745 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -429745 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4328 The citation records this snapshot. The page link may show a newer release later.	−USD 426,130 Exact value Exact value: -426130 USD 2008-01-01 – 2008-12-31: -426130 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ImmunoBiotics, Inc. · 2008-12-31 ImmunoBiotics, Inc. (edgar:1413579) Operating Cash Flow: -426130 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -426130 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4533 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 762,541 Exact value Exact value: -762541 USD 2009-01-01 – 2009-12-31: -762541 USD Inspect Net Income Open source Share or cite Citation for Net Income · ImmunoBiotics, Inc. · 2009-12-31 ImmunoBiotics, Inc. (edgar:1413579) Net Income: -762541 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -762541 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4328 The citation records this snapshot. The page link may show a newer release later.	−USD 209,314 Exact value Exact value: -209314 USD 2009-01-01 – 2009-12-31: -209314 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ImmunoBiotics, Inc. · 2009-12-31 ImmunoBiotics, Inc. (edgar:1413579) Operating Cash Flow: -209314 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-08T11:26:36Z Snapshot: a5b6e008cef46a0efd088c42c982da4cda1cbdd76c2b70c55193ac49236e00eb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1413579/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -209314 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1413579/0001213900-10-001447.txt#4533 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-08. Source filing dates and reporting periods are shown separately.

Identifiers: 0001413579, 1413579, edgar:1413579

Also known as ImmunoBiotics Inc

ImmunoBiotics, Inc.

Latest quarter

Revenue

Net margin

Operating cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation